Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 89, Issue 1, Pages 65-74
Publisher
Springer Nature
Online
2010-09-15
DOI
10.1038/clpt.2010.219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors
- (2013) Wayne A. Ray ANNALS OF INTERNAL MEDICINE
- The impact of treatment with omeprazole on the effectiveness of clopidogrel drug therapy during the first year after successful coronary stenting
- (2011) Michael N. Zairis et al. CANADIAN JOURNAL OF CARDIOLOGY
- Relation of Proton Pump Inhibitor Use After Percutaneous Coronary Intervention With Drug-Eluting Stents to Outcomes
- (2010) Michael A. Gaglia et al. AMERICAN JOURNAL OF CARDIOLOGY
- Risk of Rehospitalization for Patients Using Clopidogrel With a Proton Pump Inhibitor
- (2010) Karen M. Stockl ARCHIVES OF INTERNAL MEDICINE
- Recurrence of Acute Myocardial Infarction in Patients Discharged on Clopidogrel and a Proton Pump Inhibitor After Stent Placement for Acute Myocardial Infarction
- (2010) Jason Evanchan et al. CLINICAL CARDIOLOGY
- A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
- (2009) D. N. Juurlink et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome
- (2009) Jeremy A. Rassen et al. CIRCULATION
- Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
- (2009) M. Kazui et al. DRUG METABOLISM AND DISPOSITION
- Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
- (2009) P. Michael Ho JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
- (2009) Michelle L O'Donoghue et al. LANCET
- Antiplatelet therapy: Clopidogrel plus PPIs—a dangerous combination?
- (2009) José Luis Ferreiro et al. Nature Reviews Cardiology
- Variability in aggregometry response before and after initiation of clopidogrel therapy
- (2009) Øystein Meen et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
- (2008) et al. CIRCULATION
- Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel
- (2008) David S. Small et al. CURRENT MEDICAL RESEARCH AND OPINION
- Initial Assessment of Clinical Impact of a Drug Interaction Between Clopidogrel and Proton Pump Inhibitors
- (2008) Edmund Pezalla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
- (2008) Martine Gilard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now